ArticleScientific reports2016

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab.

Chiara Nicolazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.